Peter LeWitt

Peter A. LeWitt MD is a Board-certified neurologist and a specialist in Parkinson’s Disease and movement disorders both at Henry Ford Hospital in West Bloomfield, Michigan and in the Department of Neurology at Wayne State University School of Medicine. He has an appointment as Professor of Neurology and as the Sastry Family Endowed Chair in Neurology Research. In addition to extensive experience in conducting clinical trials for Parkinson’s disease and other neurological disorders, his research interests have included animal models and biomarkers of neurological disease, pharmacokinetic analysis of neurological drugs, and gene therapy. He is the author of more than 300 publications in basic and clinical neuroscience. Dr. LeWitt graduated from Brown University and attended its medical school. Subsequently, he completed post-graduate medical training at the University of Pennsylvania and Stanford University School of Medicine. At the National Institute of Neurological Disorders and Stroke (National Institutes of Health), he served as a research fellow in the Experimental Therapeutics Branch and had an appointment as Lieutenant Commander in the U.S. Public Health Service. Dr. LeWitt was a founding member of the Parkinson Study Group and is a Co-Chair of its Scientific Review Committee. In 1998, he was elected as an officer of the Movement Disorder Society (now the International Parkinson and Movement Disorder Society), for which he serves as a member of that organization’s Task Force for the Development of Rating Scales for Parkinson’s Disease. Dr. LeWitt has received research grants from the National Institutes of Health, the Michael J. Fox Foundation for Parkinson’s Research, The Harris Foundation Neuroscience Program, the National Parkinson Foundation, the KiMe Foundation, and other organizations. Since 2003, he has been editor-in-chief of Clinical Neuropharmacology and he has served on the editorial boards of Movement Disorders, Journal of Neural Transmission, Journal of Parkinson’s Disease, and Translational Neurodegeneration. Dr. LeWitt has been a mentor for several movement disorder fellowship trainees and has been active in educational programs conducted by the Movement Disorder Society, the American Academy of Neurology, the European Federation of Neurological Sciences, and other professional organizations. He has served as a visiting professor nationally and internationally as well as a clinical trial and neuropharmacology consultant in the development of therapies for neurological disorders.